Clinical Trials Directory

Trials / Unknown

UnknownNCT03015467

Fecal Microbiota Transplantation (FMT) for Severe Acute Pancreatitis(SAP)

Alteration of Intestinal Microflora and Efficacy and Safety of Fecal Microbiota Transplantation for Severe Acute Pancreatitis

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
First Affiliated Hospital of Chengdu Medical College · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Severe acute pancreatitis is an acute and rapid progress of the digestive system disease.Most patients with severe pancreatitis associated with intestinal mucosal barrier dysfunction.Intestinal microflora,an important part of the intestinal mucosal barrier, play an important role in the development process in the course of severe acute pancreatitis. At this stage of the study that infection of pancreas and other organs is the leading cause of death in patients with severe acute pancreatitis,and the main pathogens from intestinal micro-organisms, but the intestinal flora changes did not be mentioned. Fecal Microbiota Transplantation that has been used for treatment of inflammatory bowel disease and Clostridium difficile infection may be a new technology for regulation of intestinal mucosal dysfunction and intestinal flora unbalance.

Detailed description

Patients with acute pancreatitis will be assessed depending on APACHE II and CT score and all of them also will be separated into two parts depending on acceptation or refusal of FMT. Blood specimens from patients will be collected to analysis inflammatory factors,and fecal microbiota samples will be detection.

Conditions

Interventions

TypeNameDescription
OTHERFecal Microbiota TransplantationFecal Microbiota Transplantation and the traditional treatments for Acute Pancreatitis with gut mucosal barrier dysfunction and unbalance of gut microflora in part 1
OTHERnormal salinenormal saline and the traditional treatments for Acute Pancreatitis with gut mucosal barrier dysfunction and unbalance of gut microflora in part 2

Timeline

Start date
2016-12-01
Primary completion
2019-12-01
Completion
2020-03-01
First posted
2017-01-10
Last updated
2017-01-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03015467. Inclusion in this directory is not an endorsement.